Vir Biotechnology, Inc.
USD10.37
-0.01 (-0.13%)
CEO
Marianne De Backer
IPO Date
2019-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.41
Prev. Close
$10.38
Day Low
$10.33
Day High
$10.54
52W Low
$4.16
52W High
$11.66
Market Cap
$1.75B
Volume
0.07M
| -1.9 |
| 31 Dec 2023 | FY | -564.7% | -713.7% | -38.7% | -32.1% | 0.08 | 9.05 | -2.2 |
| 31 Dec 2022 | FY | 61.6% | 31.9% | 24.8% | 18.4% | 0.06 | 4.93 | 6.5 |
| 31 Dec 2021 | FY | 53.1% | 48.3% | 36.9% | 27.0% | 0.10 | 4.58 | 10.3 |
| 31 Dec 2020 | FY | 100.0% | -444.1% | -41.7% | -32.5% | 0.10 | 7.80 | -10.7 |
| 31 Dec 2019 | FY | 100.0% | -24568.6% | -41.2% | -34.1% | 0.00 | 6.81 | -7.8 |
| 31 Dec 2018 | FY | -11447.1% | -13350.7% | 64.7% | -60.5% | -0.06 | 2.95 | -11.7 |
| 31 Dec 2017 | FY | -41854.4% | -46880.5% | 101.4% | -27.8% | 0.00 | 15.46 | -1.4 |
| -4.9 |
| 30 Sept 2025 | Q3 | -63005.0% | -67975.4% | -20.5% | -16.0% | 0.13 | 7.25 | -1.2 |
| 30 Jun 2025 | Q2 | -7932.9% | -9139.9% | -11.7% | -9.3% | 0.11 | 7.01 | -1.6 |
| 31 Mar 2025 | Q1 | -3779.1% | -3989.6% | -11.6% | -9.3% | 0.09 | 6.79 | -1.8 |
| 31 Dec 2024 | Q4 | -617.5% | -845.2% | -9.1% | -7.5% | 0.09 | 8.71 | -2.4 |
| 30 Sept 2024 | Q3 | -8102.9% | -8979.7% | -17.2% | -14.3% | 0.09 | 8.94 | -1.2 |
| 30 Jun 2024 | Q2 | -3320.0% | -4500.1% | -9.7% | -8.3% | 0.08 | 12.51 | -2.2 |
| 31 Mar 2024 | Q1 | -74.8% | -115.8% | -4.2% | -3.6% | 0.08 | 12.90 | -5.3 |
| 31 Dec 2023 | Q4 | -533.6% | -690.9% | -7.3% | -6.0% | 0.08 | 9.05 | -2.9 |